atorvastatin has been researched along with curcumin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bisson, J; Dahlin, JL; Graham, J; Nelson, KM; Pauli, GF; Walters, MA | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Chandra, N; Mateen, AA; Naidu, MU; Raju, YS; Usharani, P | 1 |
| El-Kenawy, AE; Elshama, SS; Osman, HH | 1 |
| J B, VK; Madhusudhan, B; Ramakrishna, S | 1 |
| Chen, B; Chen, X; Cheng, D; Li, X; Lin, C; Sun, W; Wang, J; Wu, T; Xiao, H | 1 |
| Moradi, A; Nozari, E; Samadi, M | 1 |
| Biswal, J; Chandra, A; Dash, R; Goel, VK; Mohapatra, S; Prusty, SK; Sharma, T; Yadav, M | 1 |
2 review(s) available for atorvastatin and curcumin
| Article | Year |
|---|---|
The Essential Medicinal Chemistry of Curcumin.
Topics: Animals; Chemistry, Pharmaceutical; Curcumin; Humans | 2017 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
1 trial(s) available for atorvastatin and curcumin
| Article | Year |
|---|---|
Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Atorvastatin; Biomarkers; Blood Glucose; Cholesterol; Curcumin; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Oxidative Stress; Pyrroles; Triglycerides | 2008 |
5 other study(ies) available for atorvastatin and curcumin
| Article | Year |
|---|---|
Curcumin improves atorvastatin-induced myotoxicity in rats: Histopathological and biochemical evidence.
Topics: Animals; Atorvastatin; Biomarkers; Creatinine; Curcumin; Cytoprotection; L-Lactate Dehydrogenase; Muscles; Myoglobin; Potassium; Rats; Troponin | 2016 |
Preparation and characterisation of atorvastatin and curcumin-loaded chitosan nanoformulations for oral delivery in atherosclerosis.
Topics: Administration, Oral; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Chitosan; Curcumin; Delayed-Action Preparations; Diffusion; Drug Combinations; Drug Compounding; Humans; Nanocapsules; Particle Size | 2017 |
Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; Cell Death; Cell Survival; Chemokine CCL2; Curcumin; Drug Synergism; E-Selectin; Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Ligands; Lipids; Liposomes; Mice, Knockout; Particle Size; Static Electricity | 2019 |
Effect of Atorvastatin, Curcumin, and Quercetin on miR-21 and miR-122 and their correlation with TGFβ1 expression in experimental liver fibrosis.
Topics: Animals; Atorvastatin; Curcumin; Gene Expression; Liver; Liver Cirrhosis; Male; MicroRNAs; Quercetin; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Transforming Growth Factor beta1 | 2020 |
Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis.
Topics: Animals; Atherosclerosis; Atorvastatin; Chitosan; Copper; Curcumin; Drug Carriers; Glycols; Mice; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |